We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Solid Lipid Nanoparticles Based on Babassu Oil and Copaiba Oleoresin: A Promising Approach for Prostate Cancer Therapy.
- Authors
da Silva, Michael Jackson Ferreira; Rodrigues, Alisson Mendes; Costa, Maria Célia Pires; Camara, Adriana Leandro; Cabral, Lucio Mendes; Ricci Junior, Eduardo; Vanzan, Daniel Figueiredo; Matos, Ana Paula dos Santos; da Silva Honorio, Thiago; Borges, Antonio Carlos Romão
- Abstract
Solid lipid nanoparticles (SLNs) represent promising nanostructures for drug delivery systems. This study successfully synthesized SLNs containing different proportions of babassu oil (BBS) and copaiba oleoresin (COPA) via the emulsification–ultrasonication method. Before SLN synthesis, the identification and quantification of methyl esters, such as lauric acid and β-caryophyllene, were performed via GC-MS analysis. These methyl esters were used as chemical markers and assisted in encapsulation efficiency experiments. A 22 factorial design with a center point was employed to assess the impact of stearic acid and Tween 80 on particle hydrodynamic diameter (HD) and polydispersity index (PDI). Additionally, the effects of temperature (8 ± 0.5 °C and 25 ± 1.0 °C) and time (0, 7, 15, 30, 40, and 60 days) on HD and PDI values were investigated. Zeta potential (ZP) measurements were utilized to evaluate nanoparticle stability, while transmission electron microscopy provided insights into the morphology and nanometric dimensions of the SLNs. The in vitro cytotoxic activity of the SLNs (10 µg/mL, 30 µg/mL, 40 µg/mL, and 80 µg/mL) was evaluated using the MTT assay with PC-3 and DU-145 prostate cancer cell lines. Results demonstrated that SLNs containing BBS and COPA in a 1:1 ratio exhibited a promising cytotoxic effect against prostate cancer cells, with a percentage of viable cells of 68.5% for PC-3 at a concentration of 30 µg/mL and 48% for DU-145 at a concentration of 80 µg/mL. These findings underscore the potential therapeutic applications of SLNs loaded with BBS and COPA for prostate cancer treatment.
- Subjects
PROSTATE cancer; BASE oils; CANCER treatment; NANOPARTICLES; DRUG delivery systems
- Publication
Nanomaterials (2079-4991), 2024, Vol 14, Issue 12, p1014
- ISSN
2079-4991
- Publication type
Article
- DOI
10.3390/nano14121014